Antigen of hybrid M protein and carrier for group A streptococcal vaccine
AssigneeThe University of Tennessee Research Corporation
InventorJames B. Dale
Life of this patent
Estimating the term…
Abstract
Recombinant hybrid streptococcal M protein antigens are provided which elicit protective antibodies against Group A streptococci and prevent rheumatic fever. Recombinant hybrid genes which encode the antigen are provided. Vaccine compositions and methods of administering the compositions are provided to elicit immunity against Group A streptococci.
Claims41
A recombinant hybrid Streptococcal M protein antigen, comprising a carrier fused to at least one amino-terminal peptide fragment of streptococcal M protein having an epitope that elicits opsonic antibodies to at least one group A streptococci serotype without eliciting cross-reactive antibodies to mammalian tissue antigens.
Dependencies are inferred from the claim text.